ClinicalTrials.gov
public full text
Public Domain
Citalopram vs Clomipramine vs Placebo in Recurrent Depression
citalopram and clomipramine are better than placebo in preventing new episodes of depression in patients with recurrent depression
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)#855251
- Duloxetine Versus Paroxetine for Major Depression#1102031
- Escitalopram as a Mood Stabilizer for Bipolar II Disorder#800244
- The Efficacy of Citalopram Treatment in Acute Stroke#902137
- p11 Protein Levels in Patients With Major Depressive Disorder Treated With Citalopram#1087148
Record · ID 847448
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive